← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2021-06-21

Drug application

FDA Application #

ANDA212428

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL RX

Manufacturer

Chartwell RX, LLC

First approval

2021-06-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown